GlassScriptPhysician profile
Brian M Koperek
NPI 1306894191
$2,735.17
in general payments reported to CMS, 2019-2025
30 companies · $33.87 in 2025
The $33.87 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $746 · 2020: $234 · 2021: $572 · 2022: $675 · 2023: $346 · 2024: $129 · 2025: $33.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $508.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $508.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $881.32 | 2019-2022 | |
| Therapeuticsmd, INC. | $274.52 | 2019-2021 | |
| Astellas Pharma US INC | $196.80 | 2023-2024 | Veozah |
| Mayne Pharma Commercial LLC | $171.89 | 2021-2025 | |
| Hologic Sales and Service, LLC | $137.44 | 2022-2024 | Coolseal Generator, Aptima, Acessa Provu System |
| Ethicon US, LLC | $117.23 | 2021 | |
| Coopersurgical, INC. | $101.48 | 2019-2023 | Summit Doppler |
| Shield Therapeutics INC | $96.47 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $88.51 | 2019-2021 | |
| Pfizer INC. | $79.17 | 2021-2024 | |
| Organon LLC | $73.16 | 2022 | |
| Aspira Women'S Health INC | $64.94 | 2022-2023 | Ova1 |
| Olympus America INC. | $38.05 | 2022 | |
| Myovant Sciences INC. | $37.45 | 2021 | |
| Meditrina | $34.67 | 2022-2025 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $32.80 | 2019 | |
| Smith+Nephew, INC. | $32.30 | 2019 | |
| Evofem Biosciences, INC. | $29.99 | 2021 | |
| Exeltis, USA INC. | $28.56 | 2019-2020 | |
| Channel Medsystems, INC. | $27.39 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $26.75 | 2022 | |
| Amag Pharmaceuticals, INC. | $24.53 | 2019 | |
| Biogen, INC. | $24.23 | 2024 | |
| Minerva Surgical, INC | $21.23 | 2024 | |
| Allergan, INC. | $18.67 | 2019 | |
| Merck Sharp & Dohme LLC | $18.30 | 2021 | |
| Agile Therapeutics, INC. | $17.07 | 2021 | |
| Amgen INC. | $15.02 | 2019 | |
| Avion Pharmaceuticals | $13.67 | 2021 | |
| Covidien LP | $11.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Koperek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.